Beijing Strong BiotechnologiesInc Bilan de santé
Santé financière contrôle des critères 5/6
Beijing Strong BiotechnologiesInc has a total shareholder equity of CN¥4.0B and total debt of CN¥1.2B, which brings its debt-to-equity ratio to 29.4%. Its total assets and total liabilities are CN¥5.5B and CN¥1.5B respectively. Beijing Strong BiotechnologiesInc's EBIT is CN¥639.4M making its interest coverage ratio 28.3. It has cash and short-term investments of CN¥994.6M.
Informations clés
29.4%
Ratio d'endettement
CN¥1.17b
Dette
| Ratio de couverture des intérêts | 28.3x |
| Argent liquide | CN¥994.56m |
| Fonds propres | CN¥3.96b |
| Total du passif | CN¥1.49b |
| Total des actifs | CN¥5.46b |
Mises à jour récentes de la santé financière
Recent updates
Is Beijing Strong BiotechnologiesInc (SZSE:300406) A Risky Investment?
Jul 25
Benign Growth For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Underpins Its Share Price
Jul 03An Intrinsic Calculation For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Suggests It's 40% Undervalued
Jun 14Is Now The Time To Put Beijing Strong BiotechnologiesInc (SZSE:300406) On Your Watchlist?
Mar 21Improved Earnings Required Before Beijing Strong Biotechnologies,Inc. (SZSE:300406) Stock's 25% Jump Looks Justified
Mar 03Estimating The Fair Value Of Beijing Strong Biotechnologies,Inc. (SZSE:300406)
Feb 27Analyse de la situation financière
Passif à court terme: 300406's short term assets (CN¥2.6B) exceed its short term liabilities (CN¥287.6M).
Passif à long terme: 300406's short term assets (CN¥2.6B) exceed its long term liabilities (CN¥1.2B).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 300406's net debt to equity ratio (4.3%) is considered satisfactory.
Réduire la dette: 300406's debt to equity ratio has increased from 0% to 29.4% over the past 5 years.
Couverture de la dette: 300406's debt is well covered by operating cash flow (53.3%).
Couverture des intérêts: 300406's interest payments on its debt are well covered by EBIT (28.3x coverage).